Many sites of bacterial infection such as in-dwelling catheters and orthopedic surgical sites require local rather than systemic antibiotic administration. However, currently used controlled release vehicles, such as polymeric films, release water-soluble antibiotics too quickly, whereas nonporous bone cement, used in orthopedics, release very little drug. The purpose of this study was to investigate the use of nanoparticulates composed of layered double hydroxide clays to bind various antibiotics and release them in a controlled manner. Mg–Al (carbonate) layered double hydroxides were synthesized and characterized using established methods. These clay particles were suspended in solutions of the antibiotics tetracycline, doxorubicin (DOX), 5-fluorouracil, vancomycin (VAN), sodium fusidate (SF) and antisense oligonucleotides and binding was determined following centrifugation and quantitation of the unbound fraction by UV/Vis absorbance or HPLC analysis. Drug release from layered double hydroxide clay/drug complexes dispersed in polymeric films was measured by incubation in phosphate-buffered saline (pH 7.4) at 37 °C using absorbance or HPLC analysis. Antimicrobial activity of drug released from film composites was determined using zonal inhibition studies against S. epidermidis. All drugs bound to the clay particles to various degrees. Generally, drugs released with a large burst phase of release (except DOX) with little further drug release after 4 days. Dispersion of drug/clay complexes in poly(lactic-co-glycolic acid) films resulted in a reduced burst phase of release and a slow continuous release for many weeks with effective antimicrobial amounts of VAN and SF released at later time points. Layered double hydroxide clays may be useful for controlled release applications at sites requiring long-term antibiotic exposure as they maintain the drug in a non-degraded state and release effective amounts of drug over long time periods. LDH clay/drug complexes are amenable to homogenous dispersion in polymeric films where implant coating may be optimal or required.
Drug Release Alendronate Layered Double Hydroxide Nanocomposite Film Burst Phase
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
Li F, Duan X. Layered double hydroxides. Structure and Bonding. Vol.119. In: Duan, Xue, Evans, David G (editors) Applications of layered double hydroxides. Berlin: Springer; 2006. XII.Google Scholar
Tarnawski A, Pai R, Itani R, Wyle FA. The antacid Talcid adsorbs and neutralizes all proteins secreted by H. pylori including VacA cytotoxin: a new mechanism for its ulcer-healing action? Digestion. 1999;60(5):449–55.CrossRefGoogle Scholar
Mohanambe L, Vasudevan S. Anionic clays containing anti-inflammatory drug molecules: comparison of molecular dynamics simulation and measurements. J Phys Chem B. 2005;109(32):15651–8. doi:10.1021/jp050480m.CrossRefGoogle Scholar
Ambrogi V, Fardella G, Grandolini G, Perioli L. Intercalation compounds of hydrotalcite—like anionic clays with antiinflammatory agents-I. Intercalation and in vitro release of ibuprofen. Int J Pharm. 2001;220(1–2):23–32.CrossRefGoogle Scholar
Gordijo CuR, Barbosa CsAs, Da Costa Ferreira AM, Constantino VRL, Oliveira Silva Dd. Immobilization of ibuprofen and copper-ibuprofen drugs on layered double hydroxides. J Pharm Sci. 2005;94(5):1135–48. doi:10.1002/jps.20336.CrossRefGoogle Scholar
Knetsch MLW, Koole LH. New strategies in the development of antimicrobial coatings: the example of increasing usage of silver and silver nanoparticles. Polymers. 2011;3(1):340–66. doi:10.3390/polym3010340.CrossRefGoogle Scholar
Ramritu P, Halton K, Collignon P, Cook D, Fraenkel D, Battistutta D, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008;36(2):104–17. doi:10.1016/j.ajic.2007.02.012.CrossRefGoogle Scholar
Jackson J, Leung F, Duncan C, Mugabe C, Burt H. The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength. Drug Deliv Transl Res. 2011;1(2):121–31. doi:10.1007/s13346-011-0015-5.CrossRefGoogle Scholar
Andollina A, Bertoni G, Zolezzi C, Trentani F, Trentani P, Maria Borrelli A, et al. Vancomycin and meropenem in acrylic cement: elution kinetics of in vitro bactericidal action. Chir Organi Mov. 2008;91(3):153–8. doi:10.1007/s12306-007-0025-0.CrossRefGoogle Scholar
Chakraborti M, Jackson JK, Plackett D, Brunette DM, Burt HM. Drug intercalation in layered double hydroxide clay: application in the development of a nanocomposite film for guided tissue regeneration. Int J Pharm. 2011;416(1):305–13. doi:10.1016/j.ijpharm.2011.06.016.Google Scholar